AtriCure Inc Cash Flow Conversion Efficiency
AtriCure Inc cash flow conversion efficiency. Based on the latest financial reports, AtriCure Inc (ATRC) has a cash flow conversion efficiency ratio of 0.043x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($22.19 Million) by net assets ($516.43 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of AtriCure Inc (2004–2025)
Cash flow conversion efficiency of AtriCure Inc from 2004 to 2025. This chart illustrates how AtriCure Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest AtriCure Inc stock price today for real-time trading data and today's change.
AtriCure Inc Cash Flow Conversion Ratio Explained
AtriCure Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
AtriCure Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of AtriCure Inc ranked by their cash flow conversion efficiency. Also see AtriCure Inc market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Angang Steel Co Ltd Class A
SHE:000898
|
0.036x |
|
Embotelladora Andina S.A
F:AKOB
|
0.113x |
|
Imerys SA
PA:NK
|
0.054x |
|
Stolt-Nielsen Limited
LSE:0OHK
|
0.058x |
|
Paymentus Holdings, Inc.
NYSE:PAY
|
0.080x |
|
LandBridge Company LLC
NYSE:LB
|
0.051x |
|
Jafron Biomedical Co Ltd
SHE:300529
|
0.010x |
|
Zhejiang Weixing Industrial Development Co Ltd
SHE:002003
|
0.063x |
Annual Cash Flow Conversion Efficiency for AtriCure Inc (2004–2025)
The table below shows the annual cash flow conversion efficiency of AtriCure Inc from 2004 to 2025. Review AtriCure Inc free cash flow ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $491.94 Million | $57.33 Million | 0.117x | +340.22% |
| 2024-12-31 | $460.97 Million | $12.20 Million | 0.026x | +175.24% |
| 2023-12-31 | $466.17 Million | $4.48 Million | 0.010x | +119.84% |
| 2022-12-31 | $456.75 Million | $-22.14 Million | -0.048x | -70.17% |
| 2021-12-31 | $483.76 Million | $-13.78 Million | -0.028x | +40.88% |
| 2020-12-31 | $412.39 Million | $-19.87 Million | -0.048x | +24.63% |
| 2019-12-31 | $247.34 Million | $-15.81 Million | -0.064x | -282.19% |
| 2018-12-31 | $249.38 Million | $-4.17 Million | -0.017x | +69.86% |
| 2017-12-31 | $161.17 Million | $-8.94 Million | -0.055x | +38.17% |
| 2016-12-31 | $168.44 Million | $-15.12 Million | -0.090x | -113.68% |
| 2015-12-31 | $186.69 Million | $-7.84 Million | -0.042x | +74.22% |
| 2014-12-31 | $132.54 Million | $-21.60 Million | -0.163x | -126.59% |
| 2013-12-31 | $72.60 Million | $-5.22 Million | -0.072x | +53.56% |
| 2012-12-31 | $12.50 Million | $-1.94 Million | -0.155x | -21.75% |
| 2011-12-31 | $15.61 Million | $-1.99 Million | -0.127x | -6267.96% |
| 2010-12-31 | $16.74 Million | $-33.43K | -0.002x | -108.13% |
| 2009-12-31 | $17.09 Million | $419.95K | 0.025x | +112.53% |
| 2008-12-31 | $29.12 Million | $-5.71 Million | -0.196x | +12.45% |
| 2007-12-31 | $36.24 Million | $-8.12 Million | -0.224x | +44.85% |
| 2006-12-31 | $30.69 Million | $-12.47 Million | -0.406x | -130.28% |
| 2005-12-31 | $43.18 Million | $-7.62 Million | -0.176x | -226.84% |
| 2004-12-31 | $-27.33 Million | $-3.80 Million | 0.139x | -- |
About AtriCure Inc
AtriCure, Inc. engages in the development, manufacture, and sale of devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, the Asia-Pacific, and internationally. It offers Isolator Synergy Ablation System clamps, a single-use disposable radio frequency products; m… Read more